| Year |
|---|
| Current Assets |
| Cash & Short Term Investments |
| Cash And Cash Equivalents |
| Short Term Investments |
| Net Receivables |
| Inventory |
| Other Current Assets |
| Non-Current Assets |
| Property, Plant & Equipment |
| Goodwill And Intangible Assets |
| Goodwill |
| Intangible Assets |
| Long Term Investments |
| Tax Assets |
| Other Non-Current Assets |
| Other Assets |
| Total Assets |
| Current Liabilities |
| Accounts Payable |
| Short Term Debt |
| Tax Payables |
| Deferred Revenue |
| Other Current Liabilities |
| Total Current Liabilities |
| Total Non-Current Liabilities |
| Long-Term Debt |
| Deferred Revenue |
| Deferred Taxes Liabilities |
| Other Non Current liabilities |
| Total Liabilities |
| Other Liabilities |
| Stockholders Equity |
| Common Stock |
| Retained Earnings |
| Accumulated Other Comprehensive Income/Loss |
| Other Shareholders Equity |
| Total Liabilities and Stockholders Equity |
Aarti Pharmalabs Limited
AARTIPHARM.NS
NSE
679.4INR55 (-0.25%)
AARTIPHARM.NS Financial Statements
Retained Earning Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Retained Earnings (Previous Year) | 8.89B | 7.17B |
| Net Income | 2.17B | 1.93B |
| Stock Repurchases | 0 | 0 |
| Dividend Paid | -181.25M | -181.25M |
| Retained Earnings | 10.86B | 8.89B |
| Other Distributions | 1.78B | 1.54B |
PPE Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Gross PPE | 11.05B | 9.86B |
| Annual Depreciation | 732.35M | 625.43M |
| Capital Expenditure | -1.99B | -1.2B |
| Net PPE | 12.31B | 10.43B |
Intangible and Goodwill Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Acquisitions and Adjustments | 6K | -6K |
| Goodwill (Previous Year) | 17.8M | 17.81M |
| Goodwill | 17.81M | 17.8M |